Concord Medical Services Holdings Limited
CCM · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $1 | $0 | $0 |
| % Growth | -28.6% | 13.8% | -2.8% | – |
| Cost of Goods Sold | $0 | $1 | $1 | $1 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -20.6% | -14.3% | -32.3% | -11.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$1 | -$0 | -$1 | -$0 |
| % Margin | -138.6% | -86.2% | -111.2% | -94.4% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$1 | -$1 | -$1 | -$1 |
| Tax Expense | -$0 | -$0 | -$0 | -$0 |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -80.3% | -55.4% | -103.7% | -55.9% |
| EPS | -2,116.8 | -2,044.2 | -3,362.7 | -5,635.5 |
| % Growth | -3.6% | 39.2% | 40.3% | – |
| EPS Diluted | -2,116.8 | -2,044.2 | -3,362.7 | -5,635.5 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -90% | -64% | -85.1% | -74.9% |